| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| INCYIncyte Corporation | 20.66B | 105.24 | 701.60 | 14.76% | 24.69% | 25.55% | 1.21% | 0.01 |
| TGTXTG Therapeutics, Inc. | 4.88B | 30.71 | 204.73 | 40.8% | 13.31% | 21.87% | 1.14 | |
| AGIOAgios Pharmaceuticals, Inc. | 1.62B | 27.80 | 2.39 | 36.07% | -8.96% | -31.24% | 0.04 | |
| CLRBCellectar Biosciences, Inc. | 15.48M | 3.65 | -0.09 | -200.99% | 0.03 | |||
| CASICASI Pharmaceuticals, Inc. | 21.37M | 1.04 | -0.41 | -15.77% | -183.93% | -301.8% | 11.96 | |
| VORVor Biopharma Inc. | 308.06M | 14.06 | -0.41 | -94.52% | 0.33 | |||
| FATEFate Therapeutics, Inc. | 121.12M | 1.05 | -0.64 | -78.55% | -21.87% | -66.69% | 0.27 | |
| KPTIKaryopharm Therapeutics Inc. | 121.95M | 6.66 | -0.71 | -0.55% | -87.43% |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 36.37M | 6.16M | 1.06M | 1.07M | 460K | 253K | 1.39M | 596K | 237K | 76.99M |
| Revenue Growth % | 30.54% | -0.83% | -0.83% | 0% | -0.57% | -0.45% | 4.51% | -0.57% | -0.6% | 323.87% |
| Cost of Goods Sold | 9.57M | 14.7M | 8.44M | 12.72M | 51.27M | 50.05M | 0 | 0 | 0 | 1.26M |
| COGS % of Revenue | 0.26% | 2.38% | 7.92% | 11.94% | 111.46% | 197.83% | - | - | - | 0.02% |
| Gross Profit | 26.8M | -8.53M | -7.37M | -11.66M | -50.81M | -49.8M | 1.39M | 596K | 237K | 75.74M |
| Gross Margin % | 0.74% | -1.38% | -6.92% | -10.94% | -110.46% | -196.83% | 1% | 1% | 1% | 0.98% |
| Gross Profit Growth % | 4.46% | -1.32% | 0.14% | -0.58% | -3.36% | 0.02% | 1.03% | -0.57% | -0.6% | 318.57% |
| Operating Expenses | 35.62M | 36.81M | 30.32M | 32.14M | 21.69M | 27.11M | 115.39M | 139.15M | 194.18M | 249.47M |
| OpEx % of Revenue | 0.98% | 5.97% | 28.47% | 30.15% | 47.16% | 107.17% | 82.84% | 233.47% | 819.33% | 3.24% |
| Selling, General & Admin | 17.79M | 18.76M | 19.29M | 18.71M | 21.69M | 27.11M | 29.66M | 43.63M | 69.14M | 145.73M |
| SG&A % of Revenue | 0.49% | 3.04% | 18.11% | 17.55% | 47.16% | 107.17% | 21.3% | 73.2% | 291.71% | 1.89% |
| Research & Development | 17.83M | 18.05M | 11.03M | 13.43M | 52.07M | 51.49M | 85.73M | 95.52M | 125.05M | 103.74M |
| R&D % of Revenue | 0.49% | 2.93% | 10.36% | 12.6% | 113.2% | 203.51% | 61.54% | 160.27% | 527.62% | 1.35% |
| Other Operating Expenses | 1.31M | 0 | 0 | -154K | -52.07M | -51.49M | 0 | 0 | 0 | 0 |
| Operating Income | -559K | -30.65M | -29.25M | -31.07M | -72.5M | -76.91M | -114M | -138.55M | -193.94M | -173.73M |
| Operating Margin % | -0.02% | -4.97% | -27.47% | -29.15% | -157.62% | -304% | -81.84% | -232.47% | -818.33% | -2.26% |
| Operating Income Growth % | 0.98% | -53.82% | 0.05% | -0.06% | -1.33% | -0.06% | -0.48% | -0.22% | -0.4% | 0.1% |
| EBITDA | -503K | -30.57M | -29.18M | -31.01M | -72.44M | -76.75M | -113.22M | -137.68M | -192.91M | -172.51M |
| EBITDA Margin % | -0.01% | -4.96% | -27.4% | -29.09% | -157.48% | -303.38% | -81.27% | -231.01% | -813.97% | -2.24% |
| EBITDA Growth % | 0.99% | -59.77% | 0.05% | -0.06% | -1.34% | -0.06% | -0.48% | -0.22% | -0.4% | 0.11% |
| D&A (Non-Cash Add-back) | 56K | 81K | 76K | 59K | 64K | 158K | 783K | 868K | 1.03M | 1.22M |
| EBIT | 134K | -30.65M | -29.25M | -27.02M | -72.5M | -76.91M | -112.37M | -135.02M | -175.81M | -156.07M |
| Net Interest Income | 589K | 1.09M | 1.42M | 3.25M | 4.22M | 1.07M | -3.21M | -4.35M | 9.84M | 1.1M |
| Interest Income | 677K | 1.18M | 1.42M | 3.25M | 4.22M | 1.83M | 527K | 2.53M | 18.15M | 19.61M |
| Interest Expense | 88K | 83K | 0 | 0 | 0 | 760K | 3.74M | 6.88M | 8.31M | 18.5M |
| Other Income/Expense | 605K | 1.11M | 1.34M | 4.06M | 3.96M | 1.3M | -2.11M | -3.35M | 9.82M | -840K |
| Pretax Income | 46K | -29.54M | -27.92M | -27.02M | -68.55M | -75.62M | -116.11M | -141.9M | -184.13M | -174.57M |
| Pretax Margin % | 0% | -4.79% | -26.21% | -25.34% | -149.02% | -298.88% | -83.35% | -238.09% | -776.91% | -2.27% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Net Income | 46K | -29.54M | -27.92M | -27.02M | -68.55M | -75.62M | -116.11M | -141.9M | -184.13M | -174.57M |
| Net Margin % | 0% | -4.79% | -26.21% | -25.34% | -149.02% | -298.88% | -83.35% | -238.09% | -776.91% | -2.27% |
| Net Income Growth % | 1% | -643.11% | 0.05% | 0.03% | -1.54% | -0.1% | -0.54% | -0.22% | -0.3% | 0.05% |
| Net Income (Continuing) | 46K | -29.54M | -27.92M | -27.02M | -68.55M | -75.62M | -116.11M | -141.9M | -184.13M | -174.57M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.00 | -0.19 | -0.18 | -0.15 | -0.33 | -0.28 | -0.37 | -0.37 | -0.32 | -0.27 |
| EPS Growth % | 1% | - | 0.05% | 0.17% | -1.2% | 0.15% | -0.32% | 0% | 0.14% | 0.16% |
| EPS (Basic) | 0.00 | -0.19 | -0.18 | -0.15 | -0.33 | -0.28 | -0.37 | -0.37 | -0.32 | -0.27 |
| Diluted Shares Outstanding | 162.66M | 159.05M | 159.22M | 176.5M | 190.16M | 271.46M | 327.63M | 380.78M | 570.65M | 646.03M |
| Basic Shares Outstanding | 158.04M | 159.05M | 159.22M | 176.5M | 190.16M | 271.46M | 327.63M | 380.78M | 570.65M | 646.03M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 115.89M | 116.11M | 95.97M | 166.06M | 141.61M | 199.86M | 187.21M | 180.25M | 341.35M | 490.99M |
| Cash & Short-Term Investments | 114.04M | 115.11M | 94.95M | 163.56M | 139.32M | 196.28M | 183.72M | 172.75M | 333.7M | 406.57M |
| Cash Only | 21.52M | 13.08M | 16.6M | 10.84M | 13.64M | 9.93M | 34.87M | 56.84M | 70.02M | 79.02M |
| Short-Term Investments | 92.52M | 102.03M | 78.35M | 152.71M | 125.68M | 186.35M | 148.85M | 115.9M | 263.68M | 327.55M |
| Accounts Receivable | 1.21M | 475K | 436K | 1.17M | 802K | 722K | 1.76M | 3.14M | 1.66M | 38.8M |
| Days Sales Outstanding | 12.1 | 28.14 | 149.43 | 399.93 | 636.37 | 1.04K | 461.95 | 1.93K | 2.55K | 183.93 |
| Inventory | -1.21M | -475K | -436K | -1.17M | 0 | 0 | 0 | 0 | 0 | 38.71M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | 11.25K |
| Other Current Assets | 267K | 268K | 268K | 269K | 270K | 363K | 364K | 4.36M | 5.99M | 6.91M |
| Total Non-Current Assets | 32.87M | 14.14M | 14.34M | 19.23M | 23.91M | 70.87M | 38.83M | 10.33M | 52.73M | 102.79M |
| Property, Plant & Equipment | 207K | 183K | 102K | 59K | 2.9M | 5.95M | 5.38M | 4.94M | 4.73M | 4.19M |
| Fixed Asset Turnover | 175.71x | 33.67x | 10.44x | 18.07x | 0.16x | 0.04x | 0.26x | 0.12x | 0.05x | 18.37x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 32.66M | 13.95M | 14.24M | 18.58M | 19.65M | 63.39M | 28.65M | 0 | 43.3M | 94.52M |
| Other Non-Current Assets | 0 | 0 | 0 | 585K | 1.35M | 1.53M | 4.8M | 5.39M | 4.7M | 4.08M |
| Total Assets | 148.76M | 130.25M | 110.31M | 185.28M | 165.52M | 270.73M | 226.03M | 190.57M | 394.08M | 593.78M |
| Asset Turnover | 0.24x | 0.05x | 0.01x | 0.01x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.13x |
| Asset Growth % | -0.14% | -0.12% | -0.15% | 0.68% | -0.11% | 0.64% | -0.17% | -0.16% | 1.07% | 0.51% |
| Total Current Liabilities | 6.63M | 7.87M | 6.52M | 7.55M | 28.16M | 30.94M | 45.52M | 76.69M | 108.07M | 88.3M |
| Accounts Payable | 160K | 225K | 503K | 982K | 1.18M | 6.92M | 6.69M | 10.19M | 6.16M | 8.6M |
| Days Payables Outstanding | 6.1 | 5.59 | 21.76 | 28.17 | 8.41 | 50.46 | - | - | - | 2.5K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20.95M | 46.89M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 2.36M | 3.6M | 4.83M | 8.22M | 8.1M | 11.53M | 13.76M | 43.18M |
| Current Ratio | 17.47x | 14.76x | 14.73x | 21.99x | 5.03x | 6.46x | 4.11x | 2.35x | 3.16x | 5.56x |
| Quick Ratio | 17.65x | 14.82x | 14.80x | 22.15x | 5.03x | 6.46x | 4.11x | 2.35x | 3.16x | 5.12x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | 8.94K |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 2.2M | 28.84M | 54.1M | 33.88M | 38.06M | 225.16M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 24.04M | 49.83M | 30.21M | 35.05M | 118.48M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 2.2M | 4.8M | 4.27M | 3.67M | 3.01M | 2.27M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 104.42M |
| Total Liabilities | 6.63M | 7.87M | 6.52M | 7.55M | 30.36M | 59.78M | 99.62M | 110.58M | 146.13M | 313.46M |
| Total Debt | 0 | 0 | 0 | 0 | 2.55M | 29.72M | 55M | 55.75M | 85.9M | 121.72M |
| Net Debt | -21.52M | -13.08M | -16.6M | -10.84M | -11.09M | 19.79M | 20.13M | -1.09M | 15.88M | 42.7M |
| Debt / Equity | - | - | - | - | 0.02x | 0.14x | 0.44x | 0.70x | 0.35x | 0.43x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -6.35x | -369.23x | - | - | - | -101.20x | -30.48x | -20.13x | -23.33x | -9.39x |
| Total Equity | 142.13M | 122.38M | 103.8M | 177.73M | 135.16M | 210.95M | 126.42M | 80M | 247.95M | 280.32M |
| Equity Growth % | 0.09% | -0.14% | -0.15% | 0.71% | -0.24% | 0.56% | -0.4% | -0.37% | 2.1% | 0.13% |
| Book Value per Share | 0.87 | 0.77 | 0.65 | 1.01 | 0.71 | 0.78 | 0.39 | 0.21 | 0.43 | 0.43 |
| Total Shareholders' Equity | 142.13M | 122.38M | 103.8M | 177.73M | 135.16M | 210.95M | 126.42M | 80M | 247.95M | 280.32M |
| Common Stock | 159K | 159K | 160K | 186K | 200K | 310K | 324K | 390K | 545K | 606K |
| Retained Earnings | -928.39M | -957.92M | -985.84M | -1.01B | -1.08B | -1.16B | -1.27B | -1.41B | -1.6B | -1.77B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -213K | -53K | -207K | -183K | 132K | 78K | -173K | -219K | 185K | 261K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -24.2M | -18.37M | -20.56M | -21.01M | -43.83M | -66.65M | -95.56M | -127.38M | -167.74M | -218.62M |
| Operating CF Margin % | -0.67% | -2.98% | -19.3% | -19.71% | -95.28% | -263.45% | -68.6% | -213.72% | -707.78% | -2.84% |
| Operating CF Growth % | -3.59% | 0.24% | -0.12% | -0.02% | -1.09% | -0.52% | -0.43% | -0.33% | -0.32% | -0.3% |
| Net Income | 46K | -29.54M | -27.92M | -27.02M | -68.55M | -75.62M | -116.11M | -141.9M | -184.13M | -174.57M |
| Depreciation & Amortization | 56K | 81K | 76K | 59K | 776K | 935K | 783K | 868K | 1.03M | 1.22M |
| Stock-Based Compensation | 8.4M | 8.24M | 8.14M | 6.37M | 6.08M | 6.89M | 8.08M | 8M | 19.35M | 31.32M |
| Deferred Taxes | 2.24M | 597K | 310K | -365K | -1.33M | 488K | 191K | 0 | 0 | 0 |
| Other Non-Cash Items | 364K | 156K | 200K | 191K | 68K | 264K | 984K | 626K | -10.06M | -8.18M |
| Working Capital Changes | -35.3M | 2.09M | -1.37M | -245K | 19.13M | 383K | 10.52M | 5.03M | 6.06M | -68.41M |
| Change in Receivables | -243K | 731K | 39K | -528K | 366K | 80K | -1.04M | -1.38M | 1.49M | -36.89M |
| Change in Inventory | 0 | 0 | 0 | 0 | -366K | -80K | 1.04M | 1.38M | 0 | -37.97M |
| Change in Payables | -873K | 65K | 278K | 479K | 199K | 5.73M | -232K | 3.5M | -4.03M | 2.44M |
| Cash from Investing | 73K | 8.76M | 22.97M | -77.72M | 27.4M | -105.32M | 71.95M | 62.07M | -180.32M | -106M |
| Capital Expenditures | -90K | -57K | 0 | -16K | -413K | -401K | -207K | -431K | -830K | -680K |
| CapEx % of Revenue | 0% | 0.01% | - | 0.02% | 0.9% | 1.58% | 0.15% | 0.72% | 3.5% | 0.01% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1K | -1K | 22.97M | -77.7M | 27.81M | -339K | -1.59M | 1.23M | -179.49M | 0 |
| Cash from Financing | 2.58M | 1.17M | 1.11M | 92.97M | 19.5M | 168.35M | 48.56M | 87.26M | 362.02M | 334.37M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 0 | 1.17M | 51K | 6.95M | 204K | 224K | 3.28M | 17.35M | 118.98M | 159.08M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -24.29M | -18.43M | -20.56M | -21.02M | -44.24M | -67.05M | -95.76M | -127.81M | -168.57M | -219.3M |
| FCF Margin % | -0.67% | -2.99% | -19.3% | -19.72% | -96.18% | -265.03% | -68.75% | -214.45% | -711.28% | -2.85% |
| FCF Growth % | -3.63% | 0.24% | -0.12% | -0.02% | -1.1% | -0.52% | -0.43% | -0.33% | -0.32% | -0.3% |
| FCF per Share | -0.15 | -0.12 | -0.13 | -0.12 | -0.23 | -0.25 | -0.29 | -0.34 | -0.30 | -0.34 |
| FCF Conversion (FCF/Net Income) | -526.00x | 0.62x | 0.74x | 0.78x | 0.64x | 0.88x | 0.82x | 0.90x | 0.91x | 1.25x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 0.03% | -22.33% | -24.69% | -19.19% | -43.82% | -43.7% | -68.84% | -137.49% | -112.29% | -66.09% |
| Return on Invested Capital (ROIC) | -0.4% | -19.99% | -22.33% | -18.34% | -37.38% | -32.52% | -45.32% | -92.18% | -84.88% | -44.41% |
| Gross Margin | 73.68% | -138.48% | -692.21% | -1093.53% | -11046.09% | -19683.4% | 100% | 100% | 100% | 98.37% |
| Net Margin | 0.13% | -479.34% | -2621.22% | -2534.43% | -14901.74% | -29888.14% | -8335.39% | -23808.89% | -77690.72% | -226.73% |
| Debt / Equity | - | - | - | - | 0.02x | 0.14x | 0.44x | 0.70x | 0.35x | 0.43x |
| Interest Coverage | -6.35x | -369.23x | - | - | - | -101.20x | -30.48x | -20.13x | -23.33x | -9.39x |
| FCF Conversion | -526.00x | 0.62x | 0.74x | 0.78x | 0.64x | 0.88x | 0.82x | 0.90x | 0.91x | 1.25x |
| Revenue Growth | 3054.47% | -83.06% | -82.72% | 0.09% | -56.85% | -45% | 450.59% | -57.21% | -60.23% | 32386.92% |
| 2024 | |
|---|---|
| Revenues Before Adjustments | 89.42M |
| Revenues Before Adjustments Growth | - |
| Product | 76.5M |
| Product Growth | - |
| Sales Returns And Allowance | -225K |
| Sales Returns And Allowance Growth | - |
| Government Rebates | -926K |
| Government Rebates Growth | - |
| Chargeback And Distributor Service Fees | -11.77M |
| Chargeback And Distributor Service Fees Growth | - |
| Total Gross To Net Adjustments | -12.92M |
| Total Gross To Net Adjustments Growth | - |
Geron Corporation (GERN) reported $183.4M in revenue for fiscal year 2024. This represents a 7423% increase from $2.4M in 2011.
Geron Corporation (GERN) grew revenue by 32386.9% over the past year. This is strong growth.
Geron Corporation (GERN) reported a net loss of $80.0M for fiscal year 2024.
Geron Corporation (GERN) has a return on equity (ROE) of -66.1%. Negative ROE indicates the company is unprofitable.
Geron Corporation (GERN) had negative free cash flow of $132.8M in fiscal year 2024, likely due to heavy capital investments.